At Washington Patent Panel, Academia and Private Sector Duke It Out | GenomeWeb

WASHINGTON, Sept. 24 - At a consumer-oriented panel discussion about the merits of gene-related patents, two salient points managed to bubble to the surface: Academic types and corporate folks may agree that patents are the linchpins of innovation, but they disagree over what R&D stage a patent should be awarded.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.